Clinical and immunological features of CANOMAD were investigated in a study and defined by the presence of serum IgM antibodies including gangliosides: GDlb, GD3, GT1b and GQ1b (10).
Welcome to the website of Buhlmann Diagnostics Corp. By continuing your visit to our website you will be deemed to have accepted the Terms of Use. If you don't wish to accept the Terms of Use please discontinue your visit. OK
